Mitsubishi UFJ Trust & Banking’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-62,700
Closed -$6.23M 814
2018
Q2
$6.23M Sell
62,700
-3,420
-5% -$295K 0.01% 703
2018
Q1
$5.36M Buy
66,120
+540
+0.8% +$43.6K 0.01% 705
2017
Q4
$5.17M Buy
65,580
+3,770
+6% +$313K 0.01% 707
2017
Q3
$5.7M Sell
61,810
-1,810
-3% -$174K 0.01% 696
2017
Q2
$7.2M Sell
63,620
-1,240
-2% -$139K 0.01% 685
2017
Q1
$6.49M Sell
64,860
-410
-0.6% -$43.8K 0.01% 675
2016
Q4
$7.02M Sell
65,270
-470
-0.7% -$54.9K 0.01% 673
2016
Q3
$8.18M Buy
65,740
+70
+0.1% +$8.26K 0.02% 656
2016
Q2
$6.98M Buy
+65,670
New +$7.63M 0.02% 661

Other funds holding CBPO

Mitsubishi UFJ Trust & Banking's CBPO Position: Q3 2018 in Review

Mitsubishi UFJ Trust & Banking sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 62,700 shares — an estimated $6.23M sold.

Mitsubishi UFJ Trust & Banking first reported a position in CBPO in Q2 2016 and held it in 9 quarters. The position peaked at $8.18M in Q3 2016. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

  • Mitsubishi UFJ Trust & Banking reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 62,700 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $6.23M.
  • Mitsubishi UFJ Trust & Banking first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 9 quarters.
  • Mitsubishi UFJ Trust & Banking's China Biologic Products Holdings, Inc. position peaked at $8.18M in Q3 2016.
  • 82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q3 2018, filed 13 Nov 2018.